NeurAxis, Inc.
NRXSNYSEAMERICANHealthcareBiotechnology

About NeurAxis

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

Company Information

CEOBrian Carrico
Founded2011
IPO DateAugust 9, 2023
Employees21
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNYSEAMERICAN (NYSEAMERICAN)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone812 689 0791
Address
11611 North Meridian St, Suite 330 Carmel, Indiana 46032 United States

Corporate Identifiers

CIK0001933567
CUSIP64134X201
ISINUS64134X2018
EIN45-5079684
SIC3845

Leadership Team & Key Executives

Brian Carrico
President, Chief Executive Officer and Director
Timothy Robert Henrichs
Chief Financial Officer
Dr. Adrian Miranda
Senior Vice President of Science and Technology and Chief Medical Officer
Dr. Thomas Carrico
Chief Regulatory Officer and Compliance and Privacy Officer
Dr. Christopher Robin Brown D.D.S.
Founder, Director of Innovation and Director
Behnam Shamsian CPA
Investor Relations